Function of the CRISPR-cas system of the human pathogen: Clostridium difficile

mBio

Volumn 6, Issue 5, 2015, Pages

  Boudry, Pierre ^a,b   Semenov, Ekaterina ^c   Monot, Marc ^a   Datsenko, Kirill A ^d   Lopatina, Anna ^e   Sekulovic, Ognjen ^f   Ospina Bedoya, Maicol ^f   Fortier, Louis Charles ^f   Severinov, Konstantin ^c,e   Dupuy, Bruno ^a   Soutourina, Olga ^a,b  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c RUTGERS UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^f UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; BACTERIAL DNA; VIRUS RNA;

ARTICLE; BACTERIOPHAGE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; COMPUTER MODEL; CONTROLLED STUDY; ESCHERICHIA COLI; GENE SEQUENCE; GENE TARGETING; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SEQUENCE HOMOLOGY; CRISPR CAS SYSTEM; DNA SEQUENCE; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; MOLECULAR GENETICS;

CLOSTRIDIUM DIFFICILE; CRISPR-CAS SYSTEMS; DNA, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

EID: 84946593480     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01112-15     Document Type: Article

References (66)

1. Carroll KC, Bartlett JG. 2011. Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu Rev Microbiol 65:501-521. http://dx.doi.org/10.1146/annurev-micro-090110-102824.
2. Kuijper EJ, Coignard B, Tüll P, ESCMID Study Group for Clostridium difficile, EU Member States, European Centre for Disease Prevention and Control. 2006. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12(Suppl 6):2-18. http://dx.doi.org/10.1111/j.1469-0691.2006.01580.x.
3. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084. http://dx.doi.org/10.1016/S0140-6736(05)67420-X.
4. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7:526-536. http://dx.doi.org/10.1038/nrmicro2164.
5. Walters BA, Roberts R, Stafford R, Seneviratne E. 1983. Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy. Gut 24:206-212. http://dx.doi.org/10.1136/gut.24.3.206.
6. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K. 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375:500-503. http://dx.doi.org/10.1038/375500a0.
7. Voth DE, Ballard JD. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18:247-263. http://dx.doi.org/10.1128/CMR.18.2.247-263.2005.
8. Denève C, Janoir C, Poilane I, Fantinato C, Collignon A. 2009. New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents 33(Suppl 1):S24-S28. http://dx.doi.org/10.1016/S0924-8579(09)70012-3.
9. Dupuy B, Govind R, Antunes A, Matamouros S. 2008. Clostridium difficile toxin synthesis is negatively regulated by TcdC. J Med Microbiol 57:685-689. http://dx.doi.org/10.1099/jmm.0.47775-0.
10. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, Thomson NR, Roberts AP, Cerdeño-Tárraga AM, Wang H, Holden MT, Wright A, Churcher C, Quail MA, Baker S, Bason N, Brooks K, Chillingworth T, Cronin A, Davis P, Dowd L, Fraser A, Feltwell T, Hance Z, Holroyd S, Jagels K, Moule S, Mungall K, Price C, Rabbinowitsch E, Sharp S, Simmonds M, Stevens K, Unwin L, Whithead S, Dupuy B, Dougan G, Barrell B, Parkhill J. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 38:779-786. http://dx.doi.org/10.1038/ng1830.
11. Grissa I, Vergnaud G, Pourcel C. 2007. The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics 8:172. http://dx.doi.org/10.1186/1471-2105-8-172.
12. Westra ER, Swarts DC, Staals RH, Jore MM, Brouns SJ, van der Oost J. 2012. The CRISPRs, they are a-changin. How prokaryotes generate adaptive immunity. Annu Rev Genet 46:311-339. http://dx.doi.org/10.1146/annurev-genet-110711-155447.
13. Bhaya D, Davison M, Barrangou R. 2011. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu Rev Genet 45:273-297. http://dx.doi.org/10.1146/annurev-genet-110410-132430.
14. Makarova KS, Haft DH, Barrangou R, Brouns SJ, Charpentier E, Horvath P, Moineau S, Mojica FJ, Wolf YI, Yakunin AF, van der Oost J, Koonin EV. 2011. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 9:467-477. http://dx.doi.org/10.1038/nrmicro2577.
15. Makarova KS, Wolf YI, Koonin EV. 2013. The basic building blocks and evolution of CRISPR-CAS systems. Biochem Soc Trans 41:1392-1400. http://dx.doi.org/10.1042/BST20130038.
16. Sorek R, Lawrence CM, Wiedenheft B. 2013. CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu Rev Biochem 82:237-266. http://dx.doi.org/10.1146/annurev-biochem-072911-172315.
17. Li M, Liu H, Han J, Liu J, Wang R, Zhao D, Zhou J, Xiang H. 2013. Characterization of CRISPR RNA biogenesis and Cas6 cleavage-mediated inhibition of a provirus in the haloarchaeon Haloferax mediterranei. J Bacteriol 195:867-875. http://dx.doi.org/10.1128/JB.01688-12.
18. Maier LK, Dyall-Smith M, Marchfelder A. 2015. The adaptive immune system of Haloferax volcanii. Life 5:521-537. http://dx.doi.org/10.3390/life5010521.
19. Stoll B, Maier LK, Lange SJ, Brendel J, Fischer S, Backofen R, Marchfelder A. 2013. Requirements for a successful defence reaction by the CRISPR-Cas subtype I-B system. Biochem Soc Trans 41:1444-1448. http://dx.doi.org/10.1042/BST20130098.
20. Cass SD, Haas KA, Stoll B, Alkhnbashi O, Sharma K, Urlaub H, Backofen R, Marchfelder A, Bolt EL. 2015. The role of Cas8 in type I CRISPR interference. Biosci Rep 35:e00197. http://dx.doi.org/10.1042/ BSR20150043.
21. Peng L, Pei J, Pang H, Guo Y, Lin L, Huang R. 2014. Whole genome sequencing reveals a novel CRISPR system in industrial Clostridium acetobutylicum. J Ind Microbiol Biotechnol 41:1677-1685. http://dx.doi.org/10.1007/s10295-014-1507-3.
22. Richter H, Zoephel J, Schermuly J, Maticzka D, Backofen R, Randau L. 2012. Characterization of CRISPRRNAprocessing in Clostridium thermocellum and Methanococcus maripaludis. Nucleic Acids Res 40:9887-9896. http://dx.doi.org/10.1093/nar/gks737.
23. Brown SD, Nagaraju S, Utturkar S, De Tissera S, Segovia S, Mitchell W, Land ML, Dassanayake A, Köpke M. 2014. Comparison of singlemolecule sequencing and hybrid approaches for finishing the genome of Clostridium autoethanogenum and analysis of CRISPR systems in industrial relevant clostridia. Biotechnol Biofuels 7:40. http://dx.doi.org/10.1186/1754-6834-7-40.
24. Soutourina OA, Monot M, Boudry P, Saujet L, Pichon C, Sismeiro O, Semenova E, Severinov K, Le Bouguenec C, Coppée JY, Dupuy B, Martin-Verstraete I. 2013. Genome-wide identification of regulatory RNAs in the human pathogen Clostridium difficile. PLoS Genet 9:e1003493. http://dx.doi.org/10.1371/journal.pgen.1003493.
25. Hale CR, Majumdar S, Elmore J, Pfister N, Compton M, Olson S, Resch AM, Glover CV, III, Graveley BR, Terns RM, Terns MP. 2012. Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs. Mol Cell 45:292-302. http://dx.doi.org/10.1016/j.molcel.2011.10.023.
26. Maier LK, Lange SJ, Stoll B, Haas KA, Fischer S, Fischer E, Duchardt-Ferner E, Wöhnert J, Backofen R, Marchfelder A. 2013. Essential requirements for the detection and degradation of invaders by the Haloferax volcanii CRISPR/Cas system I-B.RNABiol 10:865-874. http://dx.doi.org/10.4161/rna.24282.
27. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403-410. http://dx.doi.org/10.1016/S0022-2836(05)80360-2.
28. Biswas A, Gagnon JN, Brouns SJ, Fineran PC, Brown CM. 2013. CRISPRTarget: bioinformatic prediction and analysis of crRNA targets. RNA Biol 10:817-827. http://dx.doi.org/10.4161/rna.24046.
29. Sekulovic O, Garneau JR, Néron A, Fortier LC. 2014. Characterization of temperate phages infecting Clostridium difficile isolates of human and animal origins. Appl Environ Microbiol 80:2555-2563. http://dx.doi.org/10.1128/AEM.00237-14.
30. Hargreaves KR, Flores CO, Lawley TD, Clokie MR. 2014. Abundant and diverse clustered regularly interspaced short palindromic repeat spacers in Clostridium difficile strains and prophages target multiple phage types within this pathogen. mBio 5(5):e01045-13. http://dx.doi.org/10.1128/mBio.01045-13.
31. Meessen-Pinard M, Sekulovic O, Fortier LC. 2012. Evidence of in vivo prophage induction during Clostridium difficile infection. Appl Environ Microbiol 78:7662-7670. http://dx.doi.org/10.1128/AEM.02275-12.
32. Goh S, Ong PF, Song KP, Riley TV, Chang BJ. 2007. The complete genome sequence of Clostridium difficile phage phiC2 and comparisons to phiCD119 and inducible prophages of CD630. Microbiology 153: 676-685. http://dx.doi.org/10.1099/mic.0.2006/002436-0.
33. Sekulovic O, Meessen-Pinard M, Fortier LC. 2011. Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens. J Bacteriol 193:2726-2734. http://dx.doi.org/10.1128/JB.00787-10.
34. Semenova E, Jore MM, Datsenko KA, Semenova A, Westra ER, Wanner B, van der Oost J, Brouns SJ, Severinov K. 2011. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc Natl Acad Sci U S A 108:10098-10103. http://dx.doi.org/10.1073/pnas.1104144108.
35. Wiedenheft B, van Duijn E, Bultema JB, Waghmare SP, Zhou K, Barendregt A, Westphal W, Heck AJ, Boekema EJ, Dickman MJ, Doudna JA. 2011. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc Natl Acad Sci U S A 108:10092-10097. http://dx.doi.org/10.1073/ pnas.1102716108.
36. Richter H, Lange SJ, Backofen R, Randau L. 2013. Comparative analysis of Cas6b processing and CRISPR RNA stability. RNA Biol 10:700-707. http://dx.doi.org/10.4161/rna.23715.
37. Datsenko KA, Pougach K, Tikhonov A, Wanner BL, Severinov K, Semenova E. 2012. Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat Commun 3:945. http://dx.doi.org/10.1038/ncomms1937.
38. Roberts AP, Allan E, Mullany P. 2014. The impact of horizontal gene transfer on the biology of Clostridium difficile. Adv Microb Physiol 65: 63-82. http://dx.doi.org/10.1016/bs.ampbs.2014.08.002.
39. Li M, Wang R, Zhao D, Xiang H. 2014. Adaptation of the Haloarcula hispanica CRISPR-Cas system to a purified virus strictly requires a priming process. Nucleic Acids Res 42:2483-2492. http://dx.doi.org/10.1093/nar/gkt1154.
40. Nunez JK, Kranzusch PJ, Noeske J, Wright AV, Davies CW, Doudna JA. 2014. Cas1-Cas2 complex formation mediates spacer acquisition during CRISPR-Cas adaptive immunity. Nat Struct Mol Biol 21:528-534. http://dx.doi.org/10.1038/nsmb.2820.
41. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E. 2011. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471: 602-607. http://dx.doi.org/10.1038/nature09886.
42. Pougach K, Semenova E, Bogdanova E, Datsenko KA, Djordjevic M, Wanner BL, Severinov K. 2010. Transcription, processing and function of CRISPR cassettes in Escherichia coli. Mol Microbiol 77:1367-1379. http://dx.doi.org/10.1111/j.1365-2958.2010.07265.x
43. Stabler RA, He M, Dawson L, Martin M, Valiente E, Corton C, Lawley TD, Sebaihia M, Quail MA, Rose G, Gerding DN, Gibert M, Popoff MR, Parkhill J, Dougan G, Wren BW. 2009. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10:R102. http://dx.doi.org/10.1186/gb-2009-10-9-r102.
44. Arakawa K, Tomita M. 2007. Selection effects on the positioning of genes and gene structures from the interplay of replication and transcription in bacterial genomes. Evol Bioinform Online 3:279-286.
45. Guy L, Roten CA. 2004. Genometric analyses of the organization of circular chromosomes: a universal pressure determines the direction of ribosomal RNA genes transcription relative to chromosome replication. Gene 340:45-52. http://dx.doi.org/10.1016/j.gene.2004.06.056.
46. Rocha EP, Danchin A. 2003. Gene essentiality determines chromosome organisation in bacteria. Nucleic Acids Res 31:6570-6577. http://dx.doi.org/10.1093/nar/gkg859.
47. Fortier LC, Sekulovic O. 2013. Importance of prophages to evolution and virulence of bacterial pathogens. Virulence 4:354-365. http://dx.doi.org/ 10.4161/viru.24498.
48. Goh S, Hussain H, Chang BJ, Emmett W, Riley TV, Mullany P. 2013. Phage phiC2 mediates transduction of Tn6215, encoding erythromycin resistance, between Clostridium difficile strains. mBio 4(6):e00840-13. http://dx.doi.org/10.1128/mBio.00840-13.
49. Brouwer MS, Roberts AP, Hussain H, Williams RJ, Allan E, Mullany P. 2013. Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers. Nat Commun 4:2601. http://dx.doi.org/ 10.1038/ncomms3601.
50. Seed KD, Lazinski DW, Calderwood SB, Camilli A. 2013. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature 494:489-491. http://dx.doi.org/10.1038/nature11927.
51. Paez-Espino D, Morovic W, Sun CL, Thomas BC, Ueda K, Stahl B, Barrangou R, Banfield JF. 2013. Strong bias in the bacterial CRISPR elements that confer immunity to phage. Nat Commun 4:1430. http://dx.doi.org/10.1038/ncomms2440.
52. Hargreaves KR, Clokie MR. 2014. Clostridium difficile phages: still difficult? Front Microbiol 5:184. http://dx.doi.org/10.3389/fmicb.2014.00184.
53. Dupuy B, Sonenshein AL. 1998. Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol 27:107-120. http://dx.doi.org/ 10.1046/j.1365-2958.1998.00663.x.
54. Bertani G. 1951. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 62:293-300.
55. André G, Even S, Putzer H, Burguière P, Croux C, Danchin A, Martin-Verstraete I, Soutourina O. 2008. S-box and T-box riboswitches and antisense RNA control a sulfur metabolic operon of Clostridium acetobutylicum. Nucleic Acids Res 36:5955-5969. http://dx.doi.org/10.1093/nar/ gkn601.
56. Rosinski-Chupin I, Soutourina O, Martin-Verstraete I. 2014. Riboswitch discovery by combining RNA-seq and genome-wide identification of transcriptional start sites. Methods Enzymol 549:3-27. http://dx.doi.org/10.1016/B978-0-12-801122-5.00001-5.
57. Dingle KE, Elliott B, Robinson E, Griffiths D, Eyre DW, Stoesser N, Vaughan A, Golubchik T, Fawley WN, Wilcox MH, Peto TE, Walker AS, Riley TV, Crook DW, Didelot X. 2014. Evolutionary history of the Clostridium difficile pathogenicity locus. Genome Biol Evol 6:36-52. http://dx.doi.org/10.1093/gbe/evt204.
58. Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O’Connor L, Ip CL, Golubchik T, Batty EM, Finney JM, Wyllie DH, Didelot X, Piazza P, Bowden R, Dingle KE, Harding RM, Crook DW, Wilcox MH, Peto TE, Walker AS. 2013. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 369:1195-1205. http://dx.doi.org/10.1056/NEJMoa1216064.
59. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, Connor TR, Harris SR, Fairley D, Bamford KB, D’Arc S, Brazier J, Brown D, Coia JE, Douce G, Gerding D, Kim HJ, Koh TH, Kato H, Senoh M, Louie T, Michell S, Butt E, Peacock SJ, Brown NM, Riley T, Songer G, Wilcox M, Pirmohamed M, Kuijper E, Hawkey P, Wren BW, Dougan G, Parkhill J, Lawley TD. 2013. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 45: 109-113. http://dx.doi.org/10.1038/ng.2478.
60. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, Martin MJ, Holt KE, Seth-Smith HM, Quail MA, Rance R, Brooks K, Churcher C, Harris D, Bentley SD, Burrows C, Clark L, Corton C, Murray V, Rose G, Thurston S, van Tonder A, Walker D, Wren BW, Dougan G, Parkhill J. 2010. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A 107:7527-7532. http://dx.doi.org/ 10.1073/pnas.0914322107.
61. Kurka H, Ehrenreich A, Ludwig W, Monot M, Rupnik M, Barbut F, Indra A, Dupuy B, Liebl W. 2014. Sequence similarity of Clostridium difficile strains by analysis of conserved genes and genome content is reflected by their ribotype affiliation. PLoS One 9:e86535. http://dx.doi.org/ 10.1371/journal.pone.0086535.
62. Moura I, Monot M, Tani C, Spigaglia P, Barbanti F, Norais N, Dupuy B, Bouza E, Mastrantonio P. 2014. Multidisciplinary analysis of a nontoxigenic Clostridium difficile strain with stable resistance to metronidazole. Antimicrob Agents Chemother 58:4957-4960. http://dx.doi.org/10.1128/AAC.02350-14.
63. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25. http://dx.doi.org/10.1186/gb-2009-10-3-r25.
64. Lemée L, Bourgeois I, Ruffin E, Collignon A, Lemeland JF, Pons JL. 2005. Multilocus sequence analysis and comparative evolution of virulence-associated genes and housekeeping genes of Clostridium difficile. Microbiology 151:3171-3180. http://dx.doi.org/10.1099/mic.0.28155-0.
65. Monot M, Orgeur M, Camiade E, Brehier C, Dupuy B. 2014. COV2HTML: a visualization and analysis tool of bacterial next generation sequencing (NGS) data for postgenomics life scientists. OMICS 18: 184-195. http://dx.doi.org/10.1089/omi.2013.0119.
66. Zuker M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415. http://dx.doi.org/10.1093/nar/gkg595.